Related Experiment Video
Updated: Aug 6, 2025

05:57
Fixation and Operational Method for Abdominal Massage in T2DM Mice
Published on: March 7, 2025
266
Combined PTEN Knockdown and Local Insulin in Chronic Experimental Diabetic Neuropathy
Vuong M Pham1,2, Prashanth Komirishetty3, Aparna Areti3
1Singapore Institute for Neurotechnology, National University of Singapore, Singapore.
Diabetes
|March 17, 2023
Summary
Local insulin and PTEN knockdown offer additive benefits for diabetic polyneuropathy (DPN) by supporting nerve growth and repair. These interventions improve nerve function and structure in DPN models, independent of blood sugar levels.
Area of Science:
- Neuroscience
- Endocrinology
- Regenerative Medicine
Background:
- Diabetic polyneuropathy (DPN) involves progressive neurodegeneration linked to hyperglycemia.
- Impaired neuronal growth and plasticity contribute to chronic DPN.
- Direct insulin signaling and PTEN knockdown show potential for neuronal support.
Purpose of the Study:
- To investigate the additive impacts of direct insulin signaling and PTEN knockdown on DPN.
- To assess these interventions in vitro and in a chronic mouse model of DPN.
- To determine if these effects are independent of glycemia.
Main Methods:
- In vitro studies on neurons and Schwann cells (SCs).
- In vivo experiments using a chronic mouse model of experimental DPN.
- Unilateral intra-hind paw injections of PTEN siRNA and local insulin.
Main Results:
- Insulin promoted neuron survival and SC proliferation in vitro.
- Combined insulin signaling and PTEN knockdown showed additive effects on neuron outgrowth and SC myelination.
- In vivo, combined interventions improved motor axon conduction, sensory loss, myelin thickness, and epidermal innervation, independent of glycemia.
- pAkt expression in dorsal root ganglion sensory neurons was improved.
Conclusions:
- Local PTEN inhibition/knockdown and insulin provide additive trophic support to sensory neurons and SCs.
- These combined interventions reverse key abnormalities in experimental DPN.
- The therapeutic effects are achieved without requiring metabolic correction (i.e., controlling glycemia).

